CompletedNCT05416229
Psilocybin-assisted therapy to reduce alcohol use
About this title
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Read the official source — NCT05416229Medication studyAges 20–70DenmarkAddiction
Understand this study
Who was this study for?
Listed age limits: 20 years to 70 years.
- Listed locations
- FrederiksbergSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: September 1, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- Anders Fink-Jensen, MD, DMSci
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- From 20 Years to 70 Years
- Official registry ID
- NCT05416229
- Official title
Show the full official title
The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Frederiksberg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Anders Fink-Jensen, MD, DMSci.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin and Maltodextrin.
Who was this study for?
Listed age limits: 20 years to 70 years.
